Emerging and resurgent infections
Measuring hygiene practices: a comparison of questionnaires with direct observations in rural Zaïre
Issues in the design and interpretation of studies to evaluate the impact of community-based interventions
Incidence estimates of late stages of trachoma among women in a hyperendemic area of central Tanzania
Nationwide prevalence study of hypertension and related non-communicable diseases in The Gambia
Resistance of falciparum malaria to chloroquine and sulfadoxine-pyrimethamine in Afghan refugee settlements in western Pakistan: surveys by the general health services using a simplified in vivo test
Optimizing the malaria data recording system through a study of case detection and treatment in Sri Lanka
Konzo associated with war in Mozambique
High prevalence of mutations in the dihydrofolate reductase gene ofPlasmodium falciparum in isolates from Tanzania without evidence of an association to clinical sulfadoxine/pyrimethamine resistance
Maternal nutrition and socio-economic status as determinants of birthweight in chronically malnourished African women
Typhoid fever in Ujung Pandang, Indonesia - high-risk groups and high-risk behaviours
Evaluation of Amplicor- and IS6110-PCR for direct detection ofMycobacterium tuberculosis complex in Singapore
Conference report: International Conference on HIV and iron, Brugge 1997
A time to eradicate and a time to control
A Status of Research on Medical Malacology in Relation to Schistosomiasis in Africa
Announcements
Errata
Human behaviour and cultural context in disease control
Human behaviour and cultural context in disease control
The relevance of anthropology for tropical public health: a historical perspective *
What anthropology can contribute to tropical medicine: overview of methods for control programmes 1
Anthropological contributions to a community-based schistosomiasis control project in northern Cameroun
Factors affecting knowledge of the symptoms of schistosomiasis in two rural areas near Ismailia, Egypt
Human behaviour, cost-effectiveness analysis and research and development priorities: the case of a schistosomiasis vaccine